Davis Polk and Ogier advised InnoCare Pharma Limited on the deal. InnoCare Pharma Limited executed its initial public offering and listing on the Hong Kong Stock…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
